Leadership & Pay ·
CVRx terminates Robert John as Chief Revenue Officer amid revised commercial outlook; appoints Paul Verrastro as interim Head of Sales
CVRXCVRx, Inc.
CVRx announced the immediate termination of Robert John as Chief Revenue Officer on August 10, 2026, citing a revised commercial outlook and the need to improve execution. Paul Verrastro has been appointed Interim Head of Sales while the company searches for a permanent successor. Mr. Verrastro brings over 30 years of medical device experience and recently served as Chief Marketing and Strategy Officer. CVRx operates in the medical device industry, developing and commercializing neuromodulation solutions for cardiovascular diseases.